Back to Agenda
Session 5, Track A: Accelerating Access to Medicines Through Collaboration
Session Chair(s)
Yatika Kohli, MBA
Chief Compliance and Strategy Officer, NoNO Inc, Canada
Tharany Ganesh, MSC
Head, Regulatory Affairs, AstraZeneca Canada Inc., Canada
Amber McLeod, PHD
Immunology, Virology, and Specialty Head, Regulatory Affairs, Abbvie Corporation, Canada
This session will focus on some international collaboration initiatives in place to support timely access to medicines in Canada. On behalf of the ACCESS (Australia, Canada, Singapore, Switzerland and United Kingdom) Consortium, Health Canada will provide updates on the ongoing work of Access New Active Substance Work group (NAS WG) including statistics, in addition to providing an update on the newly created Promise Pathway. At this session, representatives from innovative Medicines Canada (IMC) will share the findings of its survey of members’ experiences with submissions reviewed through this initiative as well as speak to the additional initiatives being taken by IMC to accelerate access to medicines for Canadians.
Learning Objective : - Understand the key performance indicators and measures of the Access NAS WG from a regulator’s perspective
- Gain awareness of the advantages, limitations and recommendations to enhance participation in the NAS WG from an industry perspective
- Explain additional IMC initiatives to accelerate access to medicines for Canadians
Speaker(s)
Jeffrey Skene, MSC
Director, Bureau of Cardiology, Allergy and Neurological Science, Health Canada, Canada
Access: Feedback from 5 Country Survey and Update from Health Canada
Laura King, MBA
Head, Regulatory Affairs, Novartis Pharmaceuticals Canada , Canada
Access: Feedback from 5 Country Survey and Update from Health Canada
Shirley Hopper, DrMed
Deputy Director, Innovative Medicines, HQA, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
International Recognition Procedure (IRP)
Jonathan Feairs
Director, Government Affairs & Public Policy, AstraZeneca Canada, Canada
Enabling Patient Access via Policy Innovation
Have an account?